VEGFA and neoplasm: Our data showed that the protein and mRNA expression of VEGF in the GAMCLCL-treated groups were significantly down-regulated in a dose-dependent manner compared to the model group, which indicated that GAMCLCL inhibited tumor vascular formation, tumor growth, and metastasis.